Case Series

Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports

Shi X, Zhou J, Qian C, Gao L, Wang B, Feng X

OncoTargets and Therapy 2020, 13:6789-6793

Published Date: 13 July 2020